Latest Supply Chain Management News

X2M Connect has signed a non-binding two-year MOU with Gateway DC covering data centre development, delivery and platform deployment across Australia and potentially Southeast Asia. The opportunity links Gateway’s planned 120MW-to-2GW-plus Darwin roadmap with X2M’s prospective pipeline exceeding 200MW, but revenue remains subject to future binding agreements.

TradeWindow is positioning itself for a primary ASX listing, appointing two seasoned Australian logistics experts to its board and reshaping its executive team to deepen market expertise and meet listing requirements.

Yowie Group's revenue declined in the first half of 2026 as it navigated supply chain shifts and cautious retail demand, but the company secured a significant Australian licensing deal and ended costly legacy litigation.

KTEK Aerosystems has obtained a key export licence from the Netherlands, enabling it to ship components to its US facility for assembly and delivery. This milestone solidifies the company’s trans-Atlantic supply chain and supports its targeted September delivery restart.

Treasury Wine Estates (ASX:TWE) plans a substantial $558.4 million post-tax non-cash charge on US assets as it takes decisive steps to right-size its supply chain. Despite this, FY26 earnings before material items beat expectations, with FY27 guidance maintained.

IperionX plans to relocate its parent company to Texas and list directly on Nasdaq, aligning its corporate structure with its US operations. The appointment of manufacturing veteran Michael J. Loparco aims to bolster the company’s industrial scale-up.

Ampol's first half 2026 earnings soared, powered by a resilient supply chain and a sharp rise in refinery margins driven by Middle East geopolitical tensions.

MaxiPARTS upgrades FY26 operating profit guidance to $14.2 million, driven by strong cost control and a $9 million inventory reduction, while bolstering its executive team with key appointments.

LTR Pharma has locked in a comprehensive commercial agreement with Strive Pharmacy, cementing its manufacturing and fulfilment infrastructure for the upcoming US launch of ROXUS®.

Skellerup has raised its FY26 net profit after tax forecast to $64-$65 million, driven by robust demand in the US and New Zealand markets, improved supply chain conditions, and favourable currency and tariff impacts.

OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.

Renascor Resources' cost study estimates its hydrofluoric acid-free purification method can produce battery-grade graphite at about US$459 per tonne, positioning it as a competitive ex-China alternative to conventional HF-based processes.